Veracyte (VCYT) Total Non-Current Liabilities (2019 - 2025)
Historic Total Non-Current Liabilities for Veracyte (VCYT) over the last 10 years, with Q3 2025 value amounting to $109.5 million.
- Veracyte's Total Non-Current Liabilities rose 2924.11% to $109.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.5 million, marking a year-over-year increase of 2924.11%. This contributed to the annual value of $123.5 million for FY2024, which is 7639.46% up from last year.
- Veracyte's Total Non-Current Liabilities amounted to $109.5 million in Q3 2025, which was up 2924.11% from $122.5 million recorded in Q2 2025.
- Veracyte's Total Non-Current Liabilities' 5-year high stood at $123.5 million during Q4 2024, with a 5-year trough of $49.1 million in Q1 2021.
- Over the past 5 years, Veracyte's median Total Non-Current Liabilities value was $77.7 million (recorded in 2022), while the average stood at $82.9 million.
- In the last 5 years, Veracyte's Total Non-Current Liabilities soared by 20203.97% in 2021 and then plummeted by 1400.8% in 2023.
- Veracyte's Total Non-Current Liabilities (Quarter) stood at $85.6 million in 2021, then decreased by 8.02% to $78.7 million in 2022, then fell by 11.06% to $70.0 million in 2023, then surged by 76.39% to $123.5 million in 2024, then decreased by 11.31% to $109.5 million in 2025.
- Its last three reported values are $109.5 million in Q3 2025, $122.5 million for Q2 2025, and $119.9 million during Q1 2025.